Bias, Corruption & Accountability

Earlier this year, the US Preventative Services Task Force (USPSTF) came out with the controversial recommendation that all adolescent and adult patients undergo depression...

From The Wire: Xtandi, a life-prolonging cancer drug, currently does not have a patent in India, meaning that Indian cancer patients are able to access...

Writing for the Huffington Post, Caroline Beaton looks into how drugs continue to make billions in sales even after they lose lawsuits for fraud and misconduct. “The persistence of Big Pharma's fraud despite ubiquitous legal action suggests that our present efforts to hold the industry accountable are ineffective,” Beaton writes. “New polices in motion will make potentially unsafe drugs even easier to bring to market and promote.”

In this interview for SciLogs, Dr. Michael P. Hengartner critiques the current research on antidepressant drugs and the state of biological psychiatry. "One has to realize...

A new study finds that stimulant prescribing rates to children continue to rise despite the well-established evidence documenting overdiagnosis of ADHD and overprescription of stimulants.

An article presents new screening tools for pediatric depression and anxiety—but fails to answer its own questions about efficacy.

-Experts comment on AstraZeneca's latest way of attempting to comply with pressures to provide open data.

From The New York Times: Tech companies are increasingly recruiting school teachers to help improve and promote their education tools in exchange for perks, including...

Breitbart reports that dozens of NHS officials with the power to decide which drugs the agency uses are also being paid by Big Pharma....

A new meta-analysis claiming to prove once and for all that antidepressants are an effective treatment for moderate to severe depression was published just a few days...

Current standards for clinical trials rely on statistical methods that allow for ineffective treatments to gain approval.

Study examines who gets approached and who gives consent for research on psychotic disorders.

The Milwaukee Journal Sentinel has issued a watchdog report titled “Illness Inflation” that examines how new medical conditions are often the product of industry...

An international study of college students reveals ubiquitous social and emotional challenges faced by young adults.

In a bellwether case, plaintiffs allege that Pfizer did not adequately warn patients that Zoloft (sertraline) would cause birth defects. The case is scheduled in Federal Court in March, and the verdict will have significant implications for future suits.

An investigative report in the Milwaukee-Wisconsin Journal Sentinel explores the pharmaceutical industries involvement in the creation of the ‘mental illness’ known as Premenstrual Dysphoric Disorder...

Pharmaceutical companies are regularly breaching industry codes of conduct in their promotion and advertising of their drugs in Europe.

A study in PLoS One shows that the number of National Heart Lung, and Blood Institute (NHLBI) funded drug trials reporting positive results declined precipitously after the implementation of the clinicaltrials.gov registry, which requires researchers to record their trial methods and outcome measures before collecting data. Of the 55 studies examined, 57% percent of those published before the implementation of clinicaltrials.gov in 2000 yielded a positive result. After 2000, only eight percent of trials claimed a significant benefit to the intervention examined.

An exclusive analysis by CNN and researchers at Harvard University found that opioid manufacturers are paying physicians huge sums of money — and that doctors with higher...

Bernie Sanders joins numerous public health groups and opposes Robert Califf's nomination to lead the FDA over industry ties.